LapIQ is backed by a medical advisory board of surgery professors from Stanford University and University of California, San Francisco.
Michael S. Klein, MD, FACS – Founder and CEO
Dr. Klein has a 20 year history of general and laparoscopic surgical practice experience. LapIQ was founded out of Dr. Klein's frustration with the lack of consistently effective trocar port closure methods in laparoscopic procedures. Dr. Klein received his medical degree from Wayne State University School of Medicine and completed his general surgery residency at Mt. Sinai Hospital Medical Center in Chicago. He has authored numerous publications on hernia-related topics. Dr. Klein is a member of the American College of Surgeons. Dr. Klein attended the Stanford GSB Program in Innovation and Entrepreneurship (PRIE12, now Ignite).
Michael Fourkas, MS – Co-Founder and COO
Mr. Fourkas has over 20 years of experience developing medical devices in start-up and Fortune 500 companies. These include MyoScience, Avantis Medical Systems, CryoVascular Systems (acquired by Boston Scientific), EndoVascular Technologies (acquired by Guidant), and Interventional Therapeutics (acquired by Target Therapeutics). He has a BSME from California Polytechnic State University in San Luis Obispo, and an MSME from Stanford University.
James Su, PhD – Chief Scientist
Dr. Su has over 12 years of experience developing medical devices and drug delivery technologies at various medical device companies including Abbott Vascular and Edwards Lifesciences. He is passionate about the development of biomaterials and applying them towards finding solutions in unmet medical needs. He holds a B.S. degree in Biomedical Engineering from The Johns Hopkins University, an M.Eng. degree in Bioengineering from UC San Diego, and a Ph.D. in Vision Science with Bioengineering emphasis from UC Berkeley. Dr. Su is well published and holds a number of patents in medical devices and drug delivery. In addition, he completed his postdoctoral research in Materials Science and Engineering and the School of Medicine at Stanford University.
Kenneth Sumner, PhD – FDA Regulatory Consultant
Dr. Sumner advises clients in the medical device industry on clinical and regulatory matters. Previously, he was Vice President, Worldwide Clinical and Regulatory Affairs for Ethicon Endo-Surgery Inc. (A Johnson & Johnson Company). Dr. Sumner has a 35-year career in the medical device regulatory arena, with affiliations to Eunoe, ATI Medical, Nellcor Puritan Bennett, Cytyc Corp., C.R. Bard, Zimmer Holdings, and Warner Lambert. Before joining industry, Dr. Sumner was an associate professor of chemistry at Bridgewater State College in Massachusetts. Dr. Sumner holds a B.S. in Chemistry from Union College, Schenectady, NY and a Ph.D. in Biochemistry from the State University of New York, Upstate Medical Center in Syracuse. He has done post-graduate work at The University of Chicago.